Evidence gap for acute pain outcomes in opioid use disorder
1. In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...
1. In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this retrospective study of Medicare claims data from 2016 to 2019, receipt of opioid use disorder (OUD) medications ...
1. In this retrospective study of Medicare claims data from 2016 to 2019, receipt of opioid use disorder (OUD) medications ...
1. Opioid therapy for the management of chronic non-cancer pain is not recommended according to new guidelines from the United ...
1. The current cohort study found that buprenorphine for treating opioid use disorder during pregnancy was associated with lower neonatal ...
1. In this study, counselors reported that patients would be more likely to access buprenorphine treatment if they had access ...
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
1. This quantitative study found that the number of providers prescribing buprenorphine/naloxone within Medicare Part D increased between 2013 and ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.